High-Performance Photodynamic Therapy of Tongue Squamous Cell Carcinoma with Multifunctional Nano-Verteporfin
Lina Yu,Zidan Xu,Guanxiong Zhu,Liting Zeng,Zeyu Zhang,Yang Yu,Siran Wang,Xin Zhang,Na Zhou,Lu Liang
DOI: https://doi.org/10.2147/ijn.s452060
IF: 7.033
2024-03-14
International Journal of Nanomedicine
Abstract:Lina Yu, 1, &ast Zidan Xu, 1, &ast Guanxiong Zhu, 1, &ast Liting Zeng, 1 Zeyu Zhang, 1 Yang Yu, 2 Siran Wang, 1 Xin Zhang, 3 Na Zhou, 3 Lu Liang 1, 4 1 Department of Preventive Dentistry, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, People's Republic of China; 2 Department of Sports and Health, Guangzhou Sport University, Guangzhou, People's Republic of China; 3 State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wailong, Taipa, Macau, People's Republic of China; 4 Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lina Yu; Lu Liang, Email ; Background: The photodynamic therapy (PDT) showed promising potential in treating tongue squamous cell carcinoma (TSCC). The Food and Drug Administration approved Verteporfin (Ver) is a powerful alternative in this field for its penetrating power and high production of reactive oxygen species (ROS). However, its applications in the treatment of TSCC are still rare. Methods: Ver was loaded onto Poly (lactic-co-glycolic acid) (PLGA) nanoparticles, followed by the modification with RGD peptide as the ligand. The nanostructured was named as RPV. In vitro assessments were conducted to evaluate the cytotoxicity of RPV through the Live/Dead assay analysis and Cell Counting Kit-8 (CCK-8) assay. Using the reactive oxygen species assay kit, the potential for inducing targeted tumor cell death upon laser irradiation by promoting ROS production was investigated. In vivo experiments involved with the biological distribution of RPV, the administration with RPV followed by laser irradiation, and the measurement of the tumor volumes. Immunohistochemical analysis was used to detect the Ki-67 expression, and apoptosis induced by RPV-treated group. Systemic toxicity was evaluated through hematoxylin-eosin staining and blood routine analysis. Real-time monitoring was employed to track RPV accumulation at tumor sites. Results: The in vitro assessments demonstrated the low cytotoxicity of RPV and indicated its potential for targeted killing TSCC cells under laser irradiation. In vivo experiments revealed significant tumor growth inhibition with RPV treatment and laser irradiation. Immunohistochemical analysis showed a notable decrease in Ki-67 expression, suggesting the effective suppression of cell proliferation, and TUNEL assay indicated the increased apoptosis in the RPV-treated group. Pathological examination and blood routine analysis revealed no significant systemic toxicity. Real-time monitoring exhibited selective accumulation of RPV at tumor sites. Conclusion: The findings collectively suggest that RPV holds promise as a safe and effective therapeutic strategy for TSCC, offering a combination of targeted drug delivery with photodynamic therapy. Keywords: photodynamic therapy, verteporfin, RGD sequence, tumor-specific drug delivery Tongue squamous cell carcinoma (TSCC) stands as a prevalent malignant tumor within the oral and maxillofacial region. 1 The American Cancer Society anticipates a substantial 18,040 new cases of tongue cancer in 2023, constituting approximately 52% of all oral cancer incidences. 2 TSCC exhibits a higher prevalence in men, with risk factors encompassing tobacco use, alcohol consumption, betel nut, genetic factors, HPV infection, and poor oral hygiene. 3 The rich blood supply and tissue abundance in the tongue, coupled with its frequent movement, contribute to the swift progression and early metastasis of TSCC. Current treatment modalities predominantly involve surgery, complemented by comprehensive approaches involving radiotherapy and chemotherapy. 4 However, these treatments carry significant side effects, impacting crucial functions such as pronunciation and swallowing, thereby influencing the overall survival and potentially leading to recurrence and metastasis. 5 Consequently, there is an urgent need to explore novel treatment techniques and drugs to enhance the prognosis of TSCC patients, ultimately improving their survival rates and impedi -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology